1. 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study. Issue 8 (August 2022) Authors: Malaba, Thokozile R; Nakatudde, Irene; Kintu, Kenneth; Colbers, Angela; Chen, Tao; Reynolds, Helen; Read, Lucy; Read, Jim; Stemmet, Lee-Ann; Mrubata, Megan; Byrne, Kelly; Seden, Kay; Twimukye, Adelline; Theunissen, Helene; Hodel, Eva Maria; Chiong, Justin; Hu, Nai-Chung; Burger, David; Wang, Duol... Journal: Lancet Issue: Volume 9:Issue 8(2022) Page Start: e534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study. Issue 16 (28th March 2022) Authors: Bularga, Anda; Hung, John; Daghem, Marwa; Stewart, Stacey; Taggart, Caelan; Wereski, Ryan; Singh, Trisha; Meah, Mohammed N.; Fujisawa, Takeshi; Ferry, Amy V.; Chiong, Justin; Jenkins, William S.; Strachan, Fiona E.; Semple, Scott; van Beek, Edwin J.R.; Williams, Michelle; Dey, Damini; Tuck, Chris... Journal: Circulation Issue: Volume 145:Issue 16(2022) Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. Issue 2 (February 2023) Authors: Khoo, Saye H; FitzGerald, Richard; Saunders, Geoffrey; Middleton, Calley; Ahmad, Shazaad; Edwards, Christopher J; Hadjiyiannakis, Dennis; Walker, Lauren; Lyon, Rebecca; Shaw, Victoria; Mozgunov, Pavel; Periselneris, Jimstan; Woods, Christie; Bullock, Katie; Hale, Colin; Reynolds, Helen; Downs, Ni... Journal: Lancet infectious diseases Issue: Volume 23:Issue 2(2023) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. (27th August 2021) Authors: Khoo, Saye H; Fitzgerald, Richard; Fletcher, Thomas; Ewings, Sean; Jaki, Thomas; Lyon, Rebecca; Downs, Nichola; Walker, Lauren; Tansley-Hancock, Olana; Greenhalf, William; Woods, Christie; Reynolds, Helen; Marwood, Ellice; Mozgunov, Pavel; Adams, Emily; Bullock, Katie; Holman, Wayne; Bula, Marcin... Journal: Journal of antimicrobial chemotherapy Issue: Volume 76:Number 12(2021) Page Start: 3286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. (19th December 2018) Authors: Rajoli, Rajith K R; Curley, Paul; Chiong, Justin; Back, David; Flexner, Charles; Owen, Andrew; Siccardi, Marco Journal: Journal of infectious diseases Issue: Volume 219:Number 11(2019) Page Start: 1735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗